254 related articles for article (PubMed ID: 17241597)
21. Australian Group on Antimicrobial Resistance Hospital-onset Staphylococcus aureus Surveillance Programme annual report, 2011.
Coombs GW; Nimmo GR; Pearson JC; Collignon PJ; Bell JM; McLaws ML; Christiansen KJ; Turnidge JD;
Commun Dis Intell Q Rep; 2013 Sep; 37(3):E210-8. PubMed ID: 24890956
[TBL] [Abstract][Full Text] [Related]
22. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
Osterlund A; Kahlmeter G; Haeggman S; Olsson-Liljequist B;
Scand J Infect Dis; 2006; 38(5):334-4. PubMed ID: 16724423
[TBL] [Abstract][Full Text] [Related]
23. Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus.
Jones RN; Castanheira M; Rhomberg PR; Woosley LN; Pfaller MA
J Clin Microbiol; 2010 Mar; 48(3):972-6. PubMed ID: 20053856
[TBL] [Abstract][Full Text] [Related]
24. Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
Edslev SM; Clausen ML; Agner T; Stegger M; Andersen PS
J Antimicrob Chemother; 2018 Apr; 73(4):856-861. PubMed ID: 29253168
[TBL] [Abstract][Full Text] [Related]
25. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
[TBL] [Abstract][Full Text] [Related]
26. Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory Standards method.
Coutant C; Olden D; Bell J; Turnidge JD
Diagn Microbiol Infect Dis; 1996 May; 25(1):9-13. PubMed ID: 8831039
[TBL] [Abstract][Full Text] [Related]
27. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
O'Neill AJ; Cove JH; Chopra I
J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
Clark SM; Loeffler A; Bond R
J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003
[TBL] [Abstract][Full Text] [Related]
29. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
[TBL] [Abstract][Full Text] [Related]
30. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
Udo EE; Al-Sweih N; Dhar R; Dimitrov TS; Mokaddas EM; Johny M; Al-Obaid IA; Gomaa HH; Mobasher LA; Rotimi VO; Al-Asar A
Med Princ Pract; 2008; 17(1):71-5. PubMed ID: 18059105
[TBL] [Abstract][Full Text] [Related]
31. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VK; Rohani MY; Kamel AG
Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
[TBL] [Abstract][Full Text] [Related]
32. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
Mason BW; Howard AJ; Magee JT
J Antimicrob Chemother; 2003 Apr; 51(4):1033-6. PubMed ID: 12654748
[TBL] [Abstract][Full Text] [Related]
33. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
Peeters KA; Mascini EM; Blok HE; Sanders CJ
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
[TBL] [Abstract][Full Text] [Related]
34. Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
Aubin GG; Bémer P; Guillouzouic A; Launay E; Geffroy L; Touchais S; Corvec S
Infect Dis (Lond); 2016 Sep; 48(9):699-702. PubMed ID: 27194514
[TBL] [Abstract][Full Text] [Related]
35. Efforts to support the development of fusidic acid in the United States.
Fernandes P; Pereira D
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S542-6. PubMed ID: 21546632
[TBL] [Abstract][Full Text] [Related]
36. Resistance to fusidic acid.
Turnidge J; Collignon P
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S35-44. PubMed ID: 10528785
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial resistance among clinical isolates of Staphylococcus aureus in Thailand from 2000 to 2005.
Tishyadhigama P; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Piboonbanakit D
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S8-18. PubMed ID: 21298843
[TBL] [Abstract][Full Text] [Related]
38. Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections? Experience from a tertiary care centre in Mumbai.
Phakade RS; Nataraj G; Kuyare SS; Khopkar US; Mehta PR
J Postgrad Med; 2012; 58(1):3-7. PubMed ID: 22387641
[TBL] [Abstract][Full Text] [Related]
39. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Afset JE; Maeland JA
Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
